US stock · Healthcare sector · Diagnostics & Research
Company Logo

Syneos Health, Inc.

SYNHNASDAQ

33.94

USD
-0.10
(-0.29%)
Market Closed
13.00P/E
9Forward P/E
0.65P/E to S&P500
3.493BMarket CAP
- -Div Yield
Upcoming Earnings
15 Feb-20 Feb
Shares Short
11/15/22
2.11M
Short % of Float
2.06%
Short % of Shares Outs.
2.05%
% Held by Insiders
0.44%
% Held by Institutions
99.31%
Beta
1.75
PEG Ratio
1.39
52w. high/low
104.17/22.89
Avg. Daily Volume
1.18M
Return %
Stock
S&P 500
1 year
(66.08)
(12.95)
3 years
(38.16)
27.86
5 years
(7.14)
54.69
Scale: |
High
Low
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
26.85
19.61
51.69
22.17
57.11
34.19
61.10
33.60
53.95
31.10
59.85
36.56
74.25
30.02
104.18
66.01
102.07
22.90
Currency: USD
- -
- -
- -
- -
- -
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
- -
- -
- -
- -
- -
12.64
16.74
16.55
22.12
24.17
29.81
35.67
42.45
45.13
42.39
50.04
52.40
Earnings per share
- -
- -
- -
- -
- -
(1.15)
(1.14)
(0.69)
(0.44)
2.02
2.08
(1.85)
0.23
1.27
1.85
2.25
2.79
FCF per share
- -
- -
- -
- -
- -
(0.45)
0.64
0.33
1.99
3.17
1.44
2.06
2.41
2.46
3.60
3.78
3.80
Dividends per share
- -
- -
- -
- -
- -
0.09
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
- -
- -
- -
- -
- -
0.09
0.18
0.29
0.48
0.36
0.58
0.59
0.53
0.62
0.48
0.55
0.94
Book Value per sh.
- -
- -
- -
- -
- -
- -
6.10
4.59
7.36
3.76
5.58
40.35
27.62
29.24
31.12
32.76
32.46
Comm.Shares outs.
- -
- -
- -
- -
- -
52
52
60
53
58
54
75
103
104
104
104
103
Avg. annual P/E ratio
- -
- -
- -
- -
- -
- -
- -
- -
(52.9)
18.7
21.3
(27.4)
188.4
38.8
31.6
38.2
13.0
P/E to S&P500
- -
- -
- -
- -
- -
- -
- -
- -
(2.9)
0.9
1.0
(1.2)
7.5
1.6
0.8
1.3
0.6
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
- -
0.0%
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
- -
- -
- -
- -
- -
656
869
995
1,179
1,399
1,611
2,672
4,390
4,676
4,416
5,213
5,407
Operating margin
- -
- -
- -
- -
- -
(6.1)%
(4.3)%
3.2%
5.4%
10.9%
9.6%
(1.1)%
3.6%
5.1%
6.6%
7.5%
8.1%
Depreciation (m)
- -
- -
- -
- -
- -
64
79
58
55
56
59
180
274
242
222
236
1,205
Net profit (m)
- -
- -
- -
- -
- -
(60)
(59)
(42)
(23)
117
113
(138)
24
131
193
235
287
Income tax rate
- -
- -
- -
- -
- -
36.8%
37.7%
(35.4)%
16.8%
10.6%
16.0%
(23.8)%
57.6%
(29.1)%
5.3%
25.5%
24.8%
Net profit margin
- -
- -
- -
- -
- -
(9.1)%
(6.8)%
(4.2)%
(2.0)%
8.4%
7.0%
(5.2)%
0.6%
2.8%
4.4%
4.5%
5.3%
Working capital (m)
- -
- -
- -
- -
- -
- -
44
58
47
(53)
56
263
(11)
46
161
112
240
Long-term debt (m)
- -
- -
- -
- -
- -
- -
586
587
415
472
486
2,946
2,737
2,550
2,902
3,016
2,983
Equity (m)
- -
- -
- -
- -
- -
- -
317
276
392
217
301
3,023
2,856
3,030
3,242
3,413
3,354
ROIC
- -
- -
- -
- -
- -
- -
(2.1)%
4.5%
2.4%
17.8%
14.9%
(1.0)%
1.4%
5.0%
1.6%
4.5%
5.4%
Return on capital
- -
- -
- -
- -
- -
- -
(2.6)%
2.4%
2.0%
12.1%
11.3%
(0.7)%
2.6%
3.1%
1.4%
4.8%
5.6%
Return on equity
- -
- -
- -
- -
- -
- -
(18.7)%
(15.0)%
(6.0)%
53.8%
37.4%
(4.6)%
0.9%
4.3%
5.9%
6.9%
8.6%
Plowback ratio
- -
- -
- -
- -
- -
107.6%
100.8%
101.2%
101.6%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
- -
- -
- -
- -
- -
- -
- -
- -
- -
156.0%
82.7%
- -
30.1%
22.3%
18.7%
29.9%
38.2%
Capital Structure
4 Nov · 2022 | Q3
All numbers in millions
Total liabilities
$ 4,844
Total assets
$ 8,198
Long-term debt
$ 2,983
Cash and equiv.
$ 170
Goodwill
$ 4,850
Retained earnings
$ 112
Common stock
103
Enterprise Value
$ 6,306
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
164
272
106
Receivables
1,304
1,345
1,525
Inventory
- -
- -
- -
Other
95
230
78
Current assets
1,562
1,738
1,766
Acc. Payable
137
114
108
Debt due
114
60
64
Other
1,266
1,404
1,483
Current liabilities
1,516
1,577
1,654
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
18.05%
20.82%
24.00%
Cash flow
4.78%
28.95%
69.96%
Earnings
21.81%
97.91%
(56.33)%
Dividends
- -
- -
- -
Book value
5.26%
3.21%
104.30%
Insider Trading
Type
Shares
Date
Klitgaard William E
Award
2,507
10/17/22
Brooks Michael Lee
Sale
500
07/28/22
Brooks Michael Lee
Sale
1,002
07/28/22
Brooks Michael Lee
Sale
500
07/21/22
Brooks Michael Lee
Sale
1,002
07/21/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
1,163
1,013
1,099
1,140
4,416
2021
1,209
1,283
1,348
1,373
5,213
2022
1,336
1,361
1,336
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.32
0.04
0.61
0.88
1.85
2021
0.37
0.40
0.75
0.73
2.25
2022
0.45
0.76
0.85
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Diagnostics & Research
CEO:
Mr. Alistair Macdonald
Full-time employees:
26,751
City:
Morrisville
Address:
1030 Sync Street
IPO:
Nov 7, 2014
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Recent News